Abuse of an obscure drug discount program (340B) is leading to higher overall health care costs and greater market distortions. Congress should reform the 340B program to eliminate these cost drivers and disincentives.
from Forbes Real Time https://www.forbes.com/sites/econostats/2017/10/10/reforming-the-340b-program-will-lower-the-price-of-prescription-drugs/
via IFTTT
No comments:
Post a Comment